Wolters Kluwer N.V. Analysis (May) 2026 | Price, Valuation & Outlook

Wolters Kluwer N.V.

ENXTAM:WKL

€ 60,38

€-1,36 (-2,20%)

60,38 €

€-1,36 (-2,20%)

End-of-day quote: 05/26/2026

Wolters Kluwer N.V. Stock Value

According to analysts, the current valuation of ENXTAM:WKL is Outperform.

Outperform

Wolters Kluwer N.V. Company Info

EPS Growth 5Y

11,07%

Market Cap

€13,82 B

Long-Term Debt

€4,03 B

Quarterly earnings

08/05/2026

Dividend

€2,46

Dividend Yield

4,08%

Founded

1836

Industry

Industrials

Country

Netherlands

Website

Wolters Kluwer N.V.

ISIN Number

NL0000395903

Website

http://wolterskluwer.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€99,50

64.79%

Last Update: 05/23/2026

Analysts: 14

Highest Price Target €160,00

Average Price Target €99,50

Lowest Price Target €73,00

In the last five quarters, Wolters Kluwer N.V.’s Price Target has fallen from €249,41 to €166,58 - a -33,21% decrease. Thridteen analysts predict that Wolters Kluwer N.V.’s share price will increase in the coming year, reaching €99,50. This would represent an increase of 64,79%.

Top growth stocks in the industrials sector (5Y.)

What does Wolters Kluwer N.V. do?

Wolters Kluwer N.V. provides professional information, software solutions, and services. Business Segments The company operates through various business segments that cater to a diverse clientele. The company’s operations are organized into five main segments: Health, Tax & Accounting, Financial & Corporate Compliance, Legal & Regulatory, and Corporate Performance & ESG. Health: This segment encompasses clinical drug databases, nursing solutions, and educational resources for improving health...

Wolters Kluwer N.V. provides professional information, software solutions, and services.

Business Segments

The company operates through various business segments that cater to a diverse clientele. The company’s operations are organized into five main segments: Health, Tax & Accounting, Financial & Corporate Compliance, Legal & Regulatory, and Corporate Performance & ESG.

Health: This segment encompasses clinical drug databases, nursing solutions, and educational resources for improving healthcare outcomes. The company provides an array of clinical decision support tools that assist healthcare professionals in delivering quality care through evidence-based insights.

Tax & Accounting: This segment focuses on professional tax and accounting software solutions, such as CCH Axcess and CCH ProSystem fx which support accounting firms across North America and Europe. Such software is designed to facilitate efficient tax processing and reporting.

Financial & Corporate Compliance Segment: This segment delivers solutions for ensuring compliance with various banking regulations. Offering platforms, such as ComplianceOne and Gainskeeper, the segment serves institutions striving for operational efficiency and regulatory adherence.

Legal & Regulatory: Providing law firms and corporate legal departments with enterprise legal management tools, this segment includes well-known products comprising Passport and TyMetrix. These solutions help clients streamline legal operations and enhance cost control.

Corporate Performance & ESG Segment: This segment integrates financial and operational performance management with environmental, social, and governance reporting solutions. It represents the company's proactive stance on responding to the increasing demand for comprehensive ESG reporting.

Business Strategy

The company's strategy, referred to as Elevate Our Value, is focused on achieving organic growth and improving operating profit margins as it aims to leverage technology to enhance its offerings. The strategy highlights several key priorities, such as driving investments in cloud-based expert solutions, transforming traditional digital information products into comprehensive expert solutions, and enriching the customer experience through advanced data analytics capabilities.

The company places emphasis on extending its reach into high-growth markets and adjacencies, thereby positioning itself strategically within emerging sectors. The company is keen on evolving its core capabilities by centralizing its product development teams and enhancing branding and communications efforts.

A vital component of the strategy is the commitment to invest approximately 10% of annual revenues into product development and innovation. This consistent investment enables the company to maintain relevancy and competitiveness in a rapidly shifting technological landscape, where evolving customer preferences and new market entrants pose challenges.

Products and Services

The company offers a wide array of products and services tailored to meet the demands of its diverse clientele. The company’s product portfolio includes:

Healthcare Solutions: These comprise clinical drug databases and educational platforms that facilitate ongoing education and improve clinical outcomes for healthcare professionals.

Tax and Accounting Software: The CCH Axcess and CCH ProSystem fx solutions enable professionals in tax and accounting sectors to streamline operations and enhance workflow efficiencies for better client service.

Regulatory Compliance Products: ComplianceOne and similar software solutions provide vital tools to financial institutions navigating complex regulations, ensuring compliance while optimizing operational processes.

Legal Management Software: With offerings, such as Passport and Legisway, the company ensures that legal professionals can manage cases, collaborate on projects, and perform compliance assessments effectively.

Corporate Performance and ESG Solutions: The suite of tools in this segment assists businesses in reporting on their economic, social, and environmental performance, responding to stakeholder pressure for transparency and accountability.

Geographical Markets

The company serves a global market with a significant presence in Europe, North America, the Asia-Pacific, and emerging markets. The company actively seeks opportunities to expand its market reach through strategic acquisitions that complement its existing product lines and capabilities.

Recent Acquisitions

In 2023, the company r made significant acquisitions, including the purchase of NurseTim, enhancing its healthcare education offerings, and Invistics, which broadened its capabilities in drug diversion detection. These acquisitions are strategically aligned with the company’s focus to extend its portfolio of solutions and maintain a competitive edge within high-growth sectors.

Customers

The company serves a diverse customer base that spans various industries, including healthcare providers, accounting firms, legal professionals, financial institutions, and corporate enterprises. The company’s customers range from individual practitioners to large multinational organizations requiring sophisticated solutions to support their operations.

Marketing

The company's marketing and distribution channels are multifaceted and include direct sales, strategic partnerships, and digital marketing initiatives. The company employs a customer-centric marketing strategy which focuses on understanding client needs, enhancing user experiences, and building long-term relationships. Through these channels, the company reaches its diverse customer base effectively, facilitating access to its extensive range of information products and services.

History

Wolters Kluwer N.V. was founded in 1836.

Wolters Kluwer N.V. Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**revenue distribution by industry:** - health: 40% - taxes & accounting: 30% - governance, risk & compliance: 20% - legal & regulation: 10% **top 3 markets:** - usa: 55% - europe: 30% - asia-pacific: 10% wolters kluwer n.v. generates the majority of its revenue from the healthcare sec...

At which locations are the company’s products manufactured?

**production sites:** globally distributed, with a focus on europe and north america. wolters kluwer n.v. is a multinational company mainly active in the fields of information services and publishing. the company does not produce its products in a traditional sense, as it primarily focuses on digit...

What strategy does Wolters Kluwer N.V. pursue for future growth?

**revenue growth:** 8.5% (estimated 2024) **profit growth:** 10.2% (estimated 2024) wolters kluwer n.v. pursues a growth strategy that heavily focuses on digital transformation and innovation. the company continuously invests in the development and enhancement of its digital products and servic...

Which raw materials are imported and from which countries?

**commodities/materials:** primarily digital content and software solutions **main source countries:** global, with a focus on developed markets wolters kluwer n.v. is a globally operating company specializing in information services and software solutions. since the company primarily offers digi...

How strong is the company’s competitive advantage?

**market share in the field of specialized information:** 20% (2024, estimate) **ebitda margin:** 27% (2024) wolters kluwer n.v. has a significant competitive advantage, which is demonstrated by its strong market position in the field of specialized information and software solutions. the company...

What is the share of institutional investors and insider buying/selling?

**institutional investor share:** approximately 70% (estimated 2025) **insider buys/sells:** no significant transactions in the last year (estimated 2025) the institutional investor share in wolters kluwer n.v. is estimated to be around 70%. this is typical for large publicly traded companies that...

What percentage market share does Wolters Kluwer N.V. have?

**market share of wolters kluwer n.v.:** 12% (estimated, 2025) **top competitors and their market shares:** 1. **thomson reuters corporation:** 15% 2. **relx group:** 14% 3. **bloomberg l.p.:** 10% 4. **s&p global inc.:** 9% 5. **moody's corporation:** 8% 6. **factset research systems inc....

Is Wolters Kluwer N.V. stock currently a good investment?

**revenue growth:** 6.5% (2024) **profit growth:** 8.2% (2024) **r&d investments:** 5% of revenue (2024) wolters kluwer n.v. recorded solid revenue growth of 6.5% in 2024, driven by continuous demand for its specialized information services and software solutions. the company also achieved a pr...

Does Wolters Kluwer N.V. pay a dividend – and how reliable is the payout?

**dividend yield:** 2.5% (2025, estimated) **dividend growth:** 5% annually (last 5 years, estimated) wolters kluwer n.v. is known for its reliable dividend policy. the company has consistently paid dividends in recent years and has regularly increased them. the current dividend yield is approxim...

New support ticket

Explore

Wolters Kluwer N.V. Stock Value

Wolters Kluwer N.V. Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the industrials sector (5Y.)

What does Wolters Kluwer N.V. do?

Wolters Kluwer N.V. Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Wolters Kluwer N.V. Stock Value

Wolters Kluwer N.V. Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the industrials sector (5Y.)

What does Wolters Kluwer N.V. do?

Wolters Kluwer N.V. Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.